证券代码：600289 证券简称： ST 信通 公告编号：2025-110 亿阳信通股份有限公司 关于第九届董事会第二十一次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 亿阳信通股份有限公司（以下称"公司"）第九届董事会第二十一次会议于 件和微信方式向全体董事、监事及高级管理人员发出了召开本次董事会会议的通 知。本次应参加会议董事 9 人，实际参加会议董事 9 人。第九届监事会 3 位监事 出席会议，会议由董事长袁义祥先生主持，公司高级管理人员列席本次会议。 本次会议符合《中华人民共和国公司法》和《公司章程》的规定。会议以记 名投票的方式，审议通过了如下议案并形成决议： 一、审议通过了《亿阳信通 2025 年半年度报告及摘要》 具体内容详见公司同日于指定媒体披露的《亿阳信通关于员工持股计划继续 延长存续期的公告》（公告编号：2025-114）。 具体内容详见公司同日于指定媒体披露的《亿阳信通 2025 年半年度报告》 及《亿阳信通 2025 年半年度报告摘要》。 本项议案已经公司董事会审计委员会审议通过，并同 ...

截 至 2025 年 6 月 30 日 ， 公 司 累 计 使 用 募 集 配 套 资 金 合 计 人 民 币 包括募集资金银行账户利息收入及尚未支付的发行费用。 国泰海通证券股份有限公司 关于 2025 年半年度募集资金存放、管理与实际使用 情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》及《上海证券 交易所上市公司自律监管指引第 1 号——规范运作》的规定，国泰海通证券股份 有限公司（以下简称公司）编制了截至 2025 年 6 月 30 日公司募集资金存放、管 理与实际使用情况的专项报告。具体如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意国泰君安证券股份有限公司吸收合并 海通证券股份有限公司并募集配套资金注册、核准国泰君安证券股份有限公司吸 收合并海通证券股份有限公司、海富通基金管理有限公司变更主要股东及实际控 制人、富国基金管理有限公司变更主要股东、海通期货股份有限公司变更主要股 东及实际控制人的批复》（证监许可〔2025〕96 号） ...

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the actual usage of the raised funds by Maiwei (Shanghai) Biotechnology Co., Ltd. for the first half of 2025, ensuring compliance with regulatory requirements and highlighting the management of funds. Fundraising Overview - The company raised a total of RMB 3,476,520,000.00 through the issuance of 99,900,000 shares at RMB 34.80 per share, with a net amount of RMB 3,303,432,172.40 after deducting issuance costs [1]. - The funds were fully received by January 10, 2022, and have been deposited in a special account approved by the board [1]. Fund Usage and Balance - As of June 30, 2025, the cumulative amount used from the raised funds is RMB 2,202,397,643.63, leaving a balance of RMB 87,409,961.81 [2][3]. - The funds were utilized for various projects, with RMB 1,930,647,129.47 specifically allocated to fundraising projects [1]. Fund Management - The company has established a fundraising management system to ensure proper storage, usage, and supervision of the funds, in line with relevant laws and regulations [2]. - A tripartite/four-party supervision agreement has been signed with financial institutions to oversee the special account for the raised funds [2]. Temporary Fund Usage - The company has temporarily used part of the idle funds to supplement working capital, with a maximum amount of RMB 125,000,000.00 approved for this purpose [3]. - As of June 30, 2025, the balance of temporarily supplemented working capital remains unpaid [3]. Cash Management - The company has also engaged in cash management with idle funds, allowing for investment in related financial products, with a total of RMB 87,344,944.99 allocated for this purpose [3]. Project Updates - The company has not used any excess funds for ongoing or new projects, nor has it repaid any bank loans with excess funds as of June 30, 2025 [3][4]. - The report indicates that the company has made adjustments to its fundraising projects, including the completion of the "Annual Production of 1,000kg Antibody Industrialization Project," with surplus funds being permanently allocated to working capital [4][5]. Compliance and Disclosure - The company has ensured timely, truthful, accurate, and complete disclosure of the fundraising and usage status, with no violations in fund management identified [4].

Core Viewpoint - The report details the fundraising and usage status of Shanghai Chengdi Xiangjiang Data Technology Co., Ltd., highlighting the total amount raised, expenditures, and management of the funds as of June 30, 2025 [1][2]. Fundraising Overview - The company raised a total of RMB 1,200 million through convertible bonds issued in August 2020, with a net amount of RMB 1,193.77 million after deducting issuance costs [1][2]. - As of June 30, 2025, the company has utilized RMB 1,011.55 million of the raised funds, leaving a balance of RMB 32.82 million [1][2]. Fund Management - The company has established a dedicated fund management system in compliance with relevant laws and regulations, ensuring that funds are stored in special accounts and used appropriately for designated projects [1][2]. - The funds are stored in accounts at Shanghai Rural Commercial Bank and China Construction Bank, with a total of RMB 119.38 million initially deposited [2]. Fund Usage - The actual investment in projects as of June 30, 2025, amounts to RMB 1,011.55 million, with RMB 175.68 million used in the current year [3][4]. - The company has temporarily supplemented working capital with RMB 35 million and RMB 40 million from the raised funds, ensuring that these do not affect the normal operation of fundraising projects [3][4]. Project Updates - The "Hutai Smart Cloud Valley Digital Technology Industrial Park Phase I" project is nearing completion, with general equipment installation expected to be completed by April 2025 [3][4]. - The company has decided to delay investments in customized equipment until formal contracts with clients are signed, to enhance fund usage efficiency [3][4]. Financial Adjustments - The company has replaced RMB 13.11 million of self-raised funds with raised funds for investment projects, which has been verified by an accounting firm [3][4]. - As of the report date, there are no violations in the management and usage of the raised funds, and all disclosures have been timely and accurate [3][4].

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and management of Yiyang Xintong Co., Ltd., highlighting the challenges faced due to judicial freezes on fundraising accounts, which have significantly impacted the company's ability to utilize the raised funds effectively. Fundraising Overview - The company raised a total of RMB 111,143.30 million through the issuance of 65,129,400 shares at a price of RMB 17.065 per share, with a net amount of RMB 109,587.29 million after deducting issuance costs of RMB 1,556.01 million [1] - As of June 30, 2025, the company had invested RMB 47,819.59 million in fundraising projects, with RMB 32,934.54 million utilized from the raised funds [2][9] Fund Management - The company established a fundraising management system in compliance with relevant laws and regulations, which was revised in 2024 to meet updated regulatory requirements [2][3] - Special accounts for fundraising were opened at various banks, and strict approval procedures were implemented to ensure the funds are used for their intended purposes [3] Judicial Freezes and Impact - Judicial freezes have cumulatively reduced the balance of the fundraising accounts by RMB 49,346.93 million, severely limiting the company's ability to use these funds [4][5] - The company has faced significant operational challenges due to these freezes, leading to a temporary halt in fundraising project implementations [5][9] Project Termination - On August 28, 2025, the company decided to terminate several fundraising projects, including the "Smart City Construction Project" and others, reallocating the remaining unused funds to supplement working capital [6][8] Financial Summary - As of June 30, 2025, the total amount raised was RMB 109,587.29 million, with RMB 32,934.54 million utilized, leaving RMB 14,885.05 million unspent from the fundraising accounts [7][9]

Core Viewpoint - The company plans to terminate several fundraising investment projects and use the remaining funds to permanently supplement its working capital due to significant changes in its internal and external environment, as well as the infeasibility of the original projects [1][2][10]. Fundraising Investment Projects - The terminated fundraising investment projects include: Smart City Construction Project, Industry Big Data Analysis and Operation Project, Cloud Security Management System Construction Project, Network Optimization Intelligent Platform Construction Project, and Regional Innovation Application Workshop Construction Project [1][2][3]. - The total amount raised for these projects was 1,111.43 million yuan, with a net amount of 1,095.87 million yuan after deducting issuance costs [3][9]. Fundraising Status - As of June 30, 2025, the actual use of the raised funds was 329.35 million yuan, leaving 790.32 million yuan remaining, which includes 296.85 million yuan in the fundraising account and 493.47 million yuan that was judicially seized due to legal disputes involving the controlling shareholder [1][2][7][10]. - The fundraising account remains frozen, preventing the company from utilizing the funds [10][14]. Reasons for Termination - The termination of the fundraising projects is primarily due to the impact of legal disputes involving the company's controlling shareholder, which has led to the freezing of the fundraising account and significant adverse effects on project implementation [2][10]. - The company has assessed the current situation and determined that the original projects are no longer suitable for its future development and do not meet the conditions for continued implementation [2][10]. Remaining Fund Usage - The company intends to use the remaining funds for daily operations and business development after terminating the fundraising projects [2][11]. - The funds previously judicially seized will also be used to permanently supplement working capital [2][11]. Decision-Making Process - The decision to terminate the fundraising projects and reallocate the remaining funds has been approved by the company's board of directors and supervisory board, and it will be submitted for approval at the upcoming shareholders' meeting [12][13]. - The supervisory board believes that this decision is prudent and will not adversely affect the company's operations or shareholder interests [12][13].

证券代码：688289 证券简称：圣湘生物 公告编号：2025-060 关于 2025 年半年度募集资金存放与实际使用情 况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证监会发布的《上市公司募集资金监管规则》和上海证券交易所发布的 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关规定， 圣湘生物科技股份有限公司（以下简称"公司"或"圣湘生物"）董事会编制了截至 2025 年 6 月 30 日止的《关于 2025 年半年度募集资金存放与实际使用情况的专项报告》， 具体说明如下： 一、募集资金基本情况 （一）实际募集资金金额、募集完成时间 根据中国证券监督管理委员会《关于同意圣湘生物科技股份有限公司首次公开发 行股票注册的批复》（证监许可[2020]1580 号），本公司于 2020 年 8 月向社会公众 公开发行人民币普通股 40,000,000 股。每股面值为人民币 1.00 元，每股发行价为人民 币 50.48 元，募集资金总额为人民币 2,019,200,000.00 元 ...

国泰海通证券股份有限公司 募集资金使用管理办法 第一章 总则 第一条 为规范国泰海通证券股份有限公司（以下简称公司）募集资金的 使用与管理，最大限度地保障投资者的权益，提高募集资金的使用效益，根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司证券发行注册管理 办法》《监管规则适用指引——发行类第 7 号》《上市公司募集资金监管规则》 《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》《香港联合交易所有限公司证券上市规则》等有关法律、法规、 规章、规范性文件、公司股票上市地上市规则（以下合称相关规则）的规定和要 求，结合《国泰海通证券股份有限公司章程》 （以下简称《公司章程》）及公司实 际情况，特制定本办法。 第二条 本办法所称募集资金，是指公司通过发行股票或者其他具有股权 性质的证券，向投资者募集并用于特定用途的资金，但不包括公司为实施股权激 励计划募集的资金。 本办法所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司应本着规范、透明的原则，按照股东会、董事会决议使用募 集资金，遵守公司的内部管理制度并履行相应的使用申请、审批及决策 ...

Core Viewpoint - The report details the fundraising activities and the usage of raised funds by Suzhou Mingzhi Technology Co., Ltd. as of June 30, 2025, highlighting the total amount raised, the allocation of funds, and the management practices in place to ensure compliance with regulations [1][2][4]. Fundraising Overview - The company raised a total of RMB 543,090,500.00 through the issuance of 30.77 million shares at a price of RMB 17.65 per share, with a net amount of RMB 489,365,155.48 after deducting fees [1][2]. - All raised funds have been deposited into a special account approved by the board, and a tripartite supervision agreement has been signed with the sponsor and the bank [2]. Fund Usage and Balance - As of June 30, 2025, the company utilized RMB 1,351,374.49 in the current year and a cumulative total of RMB 375,596,072.08 from the raised funds [2][5]. - The company earned RMB 279,043.43 from idle funds in the current year, with a cumulative earning of RMB 32,555,536.76 [2][5]. - The remaining balance of the raised funds as of June 30, 2025, is zero, indicating that all funds have been allocated or utilized [2][5]. Fund Management Practices - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure proper management and usage of the funds [2][4]. - A tripartite supervision agreement is in place to protect investor interests and ensure the proper storage of funds in designated accounts [2][4]. Project Completion and Fund Allocation - All fundraising projects have been completed as of June 30, 2025, with no idle funds requiring cash management [5][6]. - The company has permanently supplemented its working capital with surplus funds from completed projects, totaling RMB 51,155,155.92 [2][5][6]. Changes in Fund Usage - There have been no changes in the fundraising investment projects as of June 30, 2025, and no funds have been transferred or replaced [6][7].

证券代码：688693 证券简称：锴威特 公告编号：2025-043 苏州锴威特半导体股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》和《上海证券 交易所科创板上市公司自律监管指引第 1 号——规范运作》《上海证券交易所科 创板股票上市规则》等有关规定，苏州锴威特半导体股份有限公司（以下简称"公 司"或"本公司"）编制了《2025 年半年度募集资金存放与实际使用情况的专项报 告》。具体如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会于 2023 年 7 月 7 日出具的《关于同意苏州锴 威特半导体股份有限公司首次公开发行股票注册的批复》（证监许可﹝2023﹞ 发行价格为人民币 40.83 元，募集资金总额为 75,213.16 万元；扣除发行费用共 计 8,733.27 万元（不含增值税金额）后，募集资金净额为 66,479.89 万元，上述 资金已于 2023 年 8 月 14 日全部到位，经大华会计师事务所 ...